Work

A phase II trial of pirfenidone (5‐methyl‐1‐phenyl‐2‐[1H]‐pyridone), a novel anti‐fibrosing agent, in myelofibrosis with myeloid metaplasia

Year: 2001

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1046/j.1365-2141.2001.02883.x

Authors: Ruben A. Mesa, Ayalew Tefferi, Michelle A. Elliott, H. Clark Hoagland, Timothy G. Call, Georgene S. Schroeder, Soo‐Young Yoon, Chin‐Yang Li, Leigh A. Gray, S. Margolin, C. Christopher Hook

Institution: Mayo Clinic

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2048025540

FWCI: 1.759

Cites: 12

Cited by: 45

Related to: 10